Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo

Human Gene Therapy

Volumn 8, Issue 5, 1997, Pages 563-574

  Zhang, Liqian ^a   Wikenheiser, Kathryn A ^a   Whitsett, Jeffrey A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; MESSENGER RNA; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; NUDE MOUSE; RETROVIRUS; TUMOR REGRESSION; VIRUS GENE;

EID: 0030956975     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.5-563     Document Type: Article

References (39)

1. BALZARINI, J., BOHMAN, C., and DE CLERCQ, E. (1993). Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J. Biol. Chem. 268, 6332-6337.
2. BARBA, D., HARDIN, J., RAY, J., and GAGE, F.H. (1993). Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg. 79, 729-735.
3. BARBA, D., HARDIN, J., SADELAIN, M., and GAGE, F.H. (1994). Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91, 4348-4352.
4. BECK, C., CAYEUX, S., LUPTON, S.D., DORKEN, B., and BLANDENSTEIN, T. (1995). The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells. Hum. Gene Ther. 6, 1525-1530.
5. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
6. BLENKINSOPP, W.K. (1967). Proliferation of respiratory tract epithelium in the rat. Exp. Cell Res. 46, 144-154.
7. BORING, C.C., SQUIRES, T.S., and TONG, T. (1993). Cancer statistics, 1993. CA Cancer J. Clin. 43, 7-26.
8. BORRELLI, E., HEYMAN, R., HSI, M., and EVENS, R.M. (1988). Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA 85, 7572-7576.
9. BOVIATSIS, E.J., PARK, J.S., SENA-ESTEVES, M., KRAMM, C.M., CHASE, M., EFIRD, J.T., WEI, M.X., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994). Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains a intact thymidine kinase gene. Cancer Res. 54, 5745-5751.
10. CAREY, F.A., FABBRONI, G., and LAMB, D. (1992). Expression of proliferating cell nuclear antigen in lung cancer: a systematic study and correlation with DNA ploidy. Histopathology 20, 499-503.
11. COLOMBO, B.M., BENEDETTI, S., OTTOLENGHI, S., MORA, M., POLLO, B., POLI, G., and FINOCCHIARO, G. (1995). The "bystander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 6, 763-772.
12. CULVER, K.W., RAM, Z., WALLGRIDGE, S., ISHII, H., OLDHELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
13. DE CLERCQ, E. (1984). Biochemical aspects of the selective antiherpes activity of nucleoside analogous. Biochem. Pharmacol. 33, 2159-2169.
14. EZZEDDINE, Z.T., MARTUZA, R.I., PLATIKA, D., SHORT, M.P., MALICK, A., CHOI, B., and BREADEJIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase. New Biol. 3, 608-614.
15. FIELD, A.K., DAVIES, M.E., DEWITT, C., PERRY, H.C., LIOU, R., GERMERSHAUSE, J., KARKAS, J.D., ASHTON, W.T., JOHNSTON, D.B.R., and TOLMAN, R.L. (1983). 9-{[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine: A selection inhibitor of herpes group virus replication. Proc. Natl. Acad. Sci. USA 80, 4139-4143.
16. FONTANINI, G., MACCHIARINI, P., PEPE, S., RUGGIERO, A., HARDIN, M., BIGINI, D., VINGATI, S., PINGITORE, R., and ANGELETTI, A. (1992). The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer 70, 1520-1527.
17. FREEMAN, S.M., ABBOUND, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
18. GLASSER, S.W., KORFHAGEN, T.R., WERT, W.E., BRUNO, M.D., MCWILLIAMS, K.M., VORBROKER, D.K., and WHITSETT, J.A. (1991). Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice. Am. J. Physiol. 261, L349-L356.
19. GOLUMBEK, P.T., HAMZEH, F.M., JAFFEE, E.M., LEVITSKY, H., LIETMAN, P.S., and PARDOLL, D.M. (1992). Herpes Simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines. J. Immunother. 12, 224-230.
20. GRAESSMANN, A., SANDBERG, G., GUHL, E., and GRAESSMANN, M. (1994). Methylation of single sites within the herpes simplex virus tk coding region and the simian virus 40 T-antigen intron causes gene inaction. Mol. Cell. Biol. 14, 2004-2010.
21. HASEGAWA, Y., EMI, N., SHIMOKATA, K., ABE, A., KAWABE, T., HASEGAWA, T., KIRIOKA, T., and SAITO, H. (1993). Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retroviral vectors. Am. J. Respir. Cell Mol. Biol. 8, 655-661.
22. LINNOILA, I. (1990). Pathology of non-small cell lung cancer. Hematol. Oncol. Clin. North Am. 4, 1027-1051.
23. MAR, E.C., CHIOU, J.F., CHENG, Y.C., and HUANG, E.S. (1985). Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3,-dihydroxy-2-propoxymethyl)guanine. J. Virol. 53, 776-780.
24. MATTHEWS, T., and BOEHME, R. (1988). Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10, S490-S494.
25. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
26. MOOLTEN, F.L., and WELLS, J.M. (1990). Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
27. MOOLTEN, F.L., WELLS, J.M., HEYMAN, R.A., and EVENS, R.M. (1990). Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1, 125-134.
28. OLDHELD, E.H., RAM, Z., CULVER, K.W., BLAESE, R.M., and DEVROOM, H.L. (1993). Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4, 39-69.
29. PLAUTZ, G., NABEL, E.G., and NABEL, G.J. (1991). Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol. 3, 709-715.
30. RAM, Z., CULVER, K.W., WALGRIDGE, S., BLAESE, R.M., and OLDHELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
31. ROUSCULP, M.D., GOLDSMITH, K.T., and GARVER, R.I. (1992). Quantitative evaluation of retroviral gene transduction efficiency in human lung cancer cells. Hum. Gene Ther. 3, 471-477.
32. SHORTER, R.G., TITUS, J.L., and DIVERTIE, M.B. (1964). Cell turnover in the respiratory tract. Dis. Chest 46, 138-142.
33. STANLEY, K.E. (1980). Prognostic factors for survival in patients with inoperable lung cancer. J. Natl. Cancer. Inst. 63, 25-32.
34. TAKAMIYA, Y., SHORT, M.P., EZZEDDINE, Z.D., MOOLTEN, F.L., BREAKEHELD, X.O., and MARTUZA, R.L. (1992). Gene therapy of malignant brain tumors: A rat glioma line beraing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res. 33, 493-503.
35. TAKAMIYA, Y., SHORT, M.P., MOOLTEN, F.L., FLEET, C., MINETA, T., BREAKEHELD, X.O., and MARTUZA, R.L. (1993). An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg. 79, 104-110.
36. TAPSCOTT, S.J., MILLER, A.D., OLSON, J.M., BERGER, M.S., GROUDINE, M., and SPENCE, A.M. (1994). Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc. Natl. Acad. Sci. USA 91, 8185-8189.
37. THEUNISSEN, P.H.M.H., LEERS, M.P.G., and BOLLEN, E.C.M. (1992). Proliferating cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small cell lung carcinoma. Histopathology 20, 251-255.
38. WIKENHEISER, K.A., CLARK, J.C., LINNOILA, R.I., STAHLMAN, M.T., and WHITSETT, J.A. (1992). Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res. 52, 5342-5352.
39. WIKENHEISER, K.A., VORBROKER, D.K., RICE, W.R., CLARK, J.C., BACHURSKI, C.J., OIE, H.K., and WHITSETT, J.A. (1993). Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. Proc. Natl. Acad. Sci. USA 90, 11029-11033.